Literature DB >> 14997535

Why does the Ras switch "break" by oncogenic mutations?

Avital Shurki1, Arieh Warshel.   

Abstract

The elucidation of the structure of the RasGAP complex provides what is perhaps the most detailed link between protein structure and cancer causing mutations. In particular, it is known that mutations of Gln 61 destroy the GTPase activity of the complex, locks the cell in its ON state and thus, can cause cancer. It is entirely unclear however, why this specific mutation is so important. The present work uncovers the elusive role of Gln 61 by computer simulation of the GTPase reaction in Ras, RasGAP and of their mutants. Simulations of the effects of mutations of Gln 61 reproduce the corresponding observed changes in activation energies and allow us to analyze the energy contributions to these effects. It is found that Gln 61 does not operate in a direct chemical way nor by a direct electrostatic or steric interaction with the transition state (TS). Instead, oncogenic mutations of Gln 61 lead to the destruction of the exquisitely preorganized catalytic configuration of the active site of the RasGAP complex. This "allosteric" effect causes a major reduction in the electrostatic stabilization of the TS. Our findings have general relevance to other proteins that control signal transduction processes. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997535     DOI: 10.1002/prot.20004

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  33 in total

1.  Exploring challenges in rational enzyme design by simulating the catalysis in artificial kemp eliminase.

Authors:  Maria P Frushicheva; Jie Cao; Zhen T Chu; Arieh Warshel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-09       Impact factor: 11.205

2.  Computer simulations of protein functions: searching for the molecular origin of the replication fidelity of DNA polymerases.

Authors:  Jan Florián; Myron F Goodman; Arieh Warshel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

3.  Through the channel and around the channel: Validating and comparing microscopic approaches for the evaluation of free energy profiles for ion penetration through ion channels.

Authors:  Mitsunori Kato; Arieh Warshel
Journal:  J Phys Chem B       Date:  2005-10-20       Impact factor: 2.991

4.  On possible pitfalls in ab initio quantum mechanics/molecular mechanics minimization approaches for studies of enzymatic reactions.

Authors:  Marco Klähn; Sonja Braun-Sand; Edina Rosta; Arieh Warshel
Journal:  J Phys Chem B       Date:  2005-08-18       Impact factor: 2.991

5.  Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.

Authors:  Abdallah Sayyed-Ahmad; Priyanka Prakash; Alemayehu A Gorfe
Journal:  Proteins       Date:  2017-05-31

6.  Quantitative exploration of the molecular origin of the activation of GTPase.

Authors:  Ram Prasad B; Nikolay V Plotnikov; Jeronimo Lameira; Arieh Warshel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

7.  QM/MM Minimum Free Energy Path: Methodology and Application to Triosephosphate Isomerase.

Authors:  Hao Hu; Zhenyu Lu; Weitao Yang
Journal:  J Chem Theory Comput       Date:  2007-03       Impact factor: 6.006

8.  Overview of simulation studies on the enzymatic activity and conformational dynamics of the GTPase Ras.

Authors:  Priyanka Prakash; Alemayehu A Gorfe
Journal:  Mol Simul       Date:  2014-03-19       Impact factor: 2.178

Review 9.  Progress in ab initio QM/MM free-energy simulations of electrostatic energies in proteins: accelerated QM/MM studies of pKa, redox reactions and solvation free energies.

Authors:  Shina C L Kamerlin; Maciej Haranczyk; Arieh Warshel
Journal:  J Phys Chem B       Date:  2009-02-05       Impact factor: 2.991

10.  Empirical valence bond simulations of the chemical mechanism of ATP to cAMP conversion by anthrax edema factor.

Authors:  Letif Mones; Wei-Jen Tang; Jan Florián
Journal:  Biochemistry       Date:  2013-04-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.